Key Details
Price
$11.92Annual ROE
-61.30%Beta
1.24Events Calendar
Next earnings date:
Mar 11, 2025Recent quarterly earnings:
Dec 5, 2024Recent annual earnings:
Jul 11, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Nov 22, 2016Analyst ratings
Recent major analysts updates
Mar 3, 25 Citizens Capital Markets
Market OutperformJan 31, 25 JMP Securities
Market OutperformJan 7, 25 TD Cowen
BuyDec 18, 24 B of A Securities
BuyDec 9, 24 Cantor Fitzgerald
OverweightDec 6, 24 HC Wainwright & Co.
BuyDec 5, 24 Needham
BuyOct 7, 24 HC Wainwright & Co.
BuySep 27, 24 Jones Trading
BuySep 9, 24 Cantor Fitzgerald
OverweightMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
KalVista Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for KalVista Pharmaceuticals?
- Does KalVista Pharmaceuticals pay dividends?
- What sector is KalVista Pharmaceuticals in?
- What industry is KalVista Pharmaceuticals in?
- What country is KalVista Pharmaceuticals based in?
- When did KalVista Pharmaceuticals go public?
- Is KalVista Pharmaceuticals in the S&P 500?
- Is KalVista Pharmaceuticals in the NASDAQ 100?
- Is KalVista Pharmaceuticals in the Dow Jones?
- When was KalVista Pharmaceuticals's last earnings report?
- When does KalVista Pharmaceuticals report earnings?
- Should I buy KalVista Pharmaceuticals stock now?
What is the ticker symbol for KalVista Pharmaceuticals?
The ticker symbol for KalVista Pharmaceuticals is NASDAQ:KALV
Does KalVista Pharmaceuticals pay dividends?
No, KalVista Pharmaceuticals does not pay dividends
What sector is KalVista Pharmaceuticals in?
KalVista Pharmaceuticals is in the Healthcare sector
What industry is KalVista Pharmaceuticals in?
KalVista Pharmaceuticals is in the Biotechnology industry
What country is KalVista Pharmaceuticals based in?
KalVista Pharmaceuticals is headquartered in United States
When did KalVista Pharmaceuticals go public?
KalVista Pharmaceuticals's initial public offering (IPO) was on April 9, 2015
Is KalVista Pharmaceuticals in the S&P 500?
No, KalVista Pharmaceuticals is not included in the S&P 500 index
Is KalVista Pharmaceuticals in the NASDAQ 100?
No, KalVista Pharmaceuticals is not included in the NASDAQ 100 index
Is KalVista Pharmaceuticals in the Dow Jones?
No, KalVista Pharmaceuticals is not included in the Dow Jones index
When was KalVista Pharmaceuticals's last earnings report?
KalVista Pharmaceuticals's most recent earnings report was on Dec 5, 2024
When does KalVista Pharmaceuticals report earnings?
The next expected earnings date for KalVista Pharmaceuticals is Mar 11, 2025
Should I buy KalVista Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions